Share on StockTwits

Vectura Group PLC (LON:VEC)‘s stock had its “buy” rating reiterated by analysts at FinnCap in a research report issued to clients and investors on Thursday. They currently have a GBX 202 ($3.35) price objective on the stock. FinnCap’s target price indicates a potential upside of 47.99% from the company’s current price.

VEC has been the subject of a number of other recent research reports. Analysts at Canaccord Genuity reiterated a “buy” rating on shares of Vectura Group PLC in a research note on Thursday, August 21st. They now have a GBX 192 ($3.19) price target on the stock. Separately, analysts at N+1 Singer reiterated a “hold” rating on shares of Vectura Group PLC in a research note on Tuesday, August 19th. They now have a GBX 135 ($2.24) price target on the stock. Finally, analysts at N+1 Singer reiterated a “hold” rating on shares of Vectura Group PLC in a research note on Thursday, July 24th. They now have a GBX 135 ($2.24) price target on the stock. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Vectura Group PLC has an average rating of “Buy” and a consensus price target of GBX 178 ($2.95).

Shares of Vectura Group PLC (LON:VEC) traded up 0.92% during mid-day trading on Thursday, hitting GBX 136.50. 893,970 shares of the company’s stock traded hands. Vectura Group PLC has a 52 week low of GBX 101.00 and a 52 week high of GBX 171.50. The stock’s 50-day moving average is GBX 138.0 and its 200-day moving average is GBX 141.0. The company’s market cap is £545.8 million.

Vectura Group plc (LON:VEC) is a developer of therapies principally for the treatment of respiratory diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.